HK1257535A1 - 使用胎盤鑑定抗腫瘤化合物 - Google Patents
使用胎盤鑑定抗腫瘤化合物Info
- Publication number
- HK1257535A1 HK1257535A1 HK18116495.6A HK18116495A HK1257535A1 HK 1257535 A1 HK1257535 A1 HK 1257535A1 HK 18116495 A HK18116495 A HK 18116495A HK 1257535 A1 HK1257535 A1 HK 1257535A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- placenta
- identification
- antitumor compounds
- antitumor
- compounds
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261602524P | 2012-02-23 | 2012-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1257535A1 true HK1257535A1 (zh) | 2019-10-25 |
Family
ID=49006227
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100631.8A HK1200057A1 (zh) | 2012-02-23 | 2015-01-20 | 使用胎盤鑑定抗癌化合物 |
| HK18116495.6A HK1257535A1 (zh) | 2012-02-23 | 2018-12-24 | 使用胎盤鑑定抗腫瘤化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100631.8A HK1200057A1 (zh) | 2012-02-23 | 2015-01-20 | 使用胎盤鑑定抗癌化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9575054B2 (zh) |
| EP (2) | EP3338548B1 (zh) |
| ES (1) | ES2666576T3 (zh) |
| HK (2) | HK1200057A1 (zh) |
| WO (1) | WO2013126674A1 (zh) |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5192312A (en) | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
| US5190556A (en) | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
| US5372581A (en) | 1993-07-21 | 1994-12-13 | Minneapolis Children's Services Corporation | Method and apparatus for placental blood collection |
| CA2856986C (en) * | 2001-02-14 | 2019-08-13 | Anthrogenesis Corporation | Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders |
| EP1390379A4 (en) * | 2001-05-25 | 2005-02-02 | Clontech Lab Inc | FLUORESCENT CRUNCH PROTEINS AND METHODS OF USE |
| US20030187515A1 (en) * | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
| CA2495935A1 (en) * | 2002-08-13 | 2004-02-19 | The Board Of Trustees Of The University Of Illinois | Screening strategy for anticancer drugs |
| WO2005001079A2 (en) * | 2003-06-27 | 2005-01-06 | Ethicon, Incorporated | Soft tissue repair and regeneration using postpartum-derived cells |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| PE20070771A1 (es) | 2005-10-13 | 2007-08-11 | Anthrogenesis Corp | Inmunomodulacion mediante el uso de celulas madres de la placenta |
| EP2471904B1 (en) | 2005-12-29 | 2018-10-24 | Celularity, Inc. | Placental stem cell populations |
| CA2676292C (en) * | 2007-02-01 | 2017-09-19 | Dana-Farber Cancer Institute, Inc. | Cell co-culture systems and uses thereof |
| NZ597779A (en) | 2007-02-12 | 2013-07-26 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
| SI2203176T1 (sl) | 2007-09-28 | 2015-04-30 | Anthrogenesis Corporation | Tumorska supresija z uporabo humanega perfuzata placente in intermediarnih naravnih celic ubijalk, pridobljenih iz humane placente |
| CN101417934B (zh) * | 2007-10-24 | 2012-04-18 | 国鼎生物科技股份有限公司 | 分离自牛樟芝萃取物的化合物 |
| US8728805B2 (en) | 2008-08-22 | 2014-05-20 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
| EP2275442A1 (en) * | 2009-07-06 | 2011-01-19 | Ludwig-Maximilians-Universität München | Detection and vizualization of the cell cycle in living cells |
| CA2782815A1 (en) * | 2009-12-17 | 2011-06-23 | Queen's University At Kingston | Decellularized adipose tissue |
-
2013
- 2013-02-22 EP EP17202341.8A patent/EP3338548B1/en active Active
- 2013-02-22 US US14/380,014 patent/US9575054B2/en active Active
- 2013-02-22 EP EP13751855.1A patent/EP2816894B1/en active Active
- 2013-02-22 WO PCT/US2013/027288 patent/WO2013126674A1/en active Application Filing
- 2013-02-22 ES ES13751855.1T patent/ES2666576T3/es active Active
-
2015
- 2015-01-20 HK HK15100631.8A patent/HK1200057A1/zh unknown
-
2018
- 2018-12-24 HK HK18116495.6A patent/HK1257535A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2816894A1 (en) | 2014-12-31 |
| EP2816894A4 (en) | 2015-06-24 |
| EP2816894B1 (en) | 2018-01-03 |
| HK1200057A1 (zh) | 2015-07-31 |
| ES2666576T3 (es) | 2018-05-07 |
| EP3338548B1 (en) | 2020-04-08 |
| WO2013126674A1 (en) | 2013-08-29 |
| US9575054B2 (en) | 2017-02-21 |
| WO2013126674A9 (en) | 2017-06-08 |
| US20150017663A1 (en) | 2015-01-15 |
| EP3338548A1 (en) | 2018-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1198761A1 (zh) | 咪唑並吡咯啶酮化合物 | |
| EP2925129A4 (en) | PRO-NEUROGENIC COMPOUNDS | |
| GB201209138D0 (en) | Compounds | |
| GB201214750D0 (en) | Compounds | |
| GB201215357D0 (en) | Compounds | |
| EP2861588A4 (en) | NEW THERAPEUTIC AGENTS FOR BRAIN CANCER | |
| EP2887803A4 (en) | PRO-NEUROGENIC COMPOUNDS | |
| EP2828262A4 (en) | IMIDAZOTRIAZINONVERBINDUNGEN | |
| GB201204985D0 (en) | Compounds | |
| GB201204125D0 (en) | Compounds | |
| HK1211927A1 (zh) | 聚蛋白多糖酶抑制劑 | |
| HK1209391A1 (zh) | 車輛定位 | |
| EP2800747A4 (en) | POLYMORPHY OF PERAMPANEL | |
| GB201209096D0 (en) | Compounds | |
| GB201202393D0 (en) | Polymorphs | |
| GB201219820D0 (en) | Compounds | |
| HK1209287A1 (zh) | 配方增强劑 | |
| EP2892529A4 (en) | USES OF (-) - PERHEXILINE | |
| GB201220418D0 (en) | Identification of materials | |
| GB201217310D0 (en) | Compounds | |
| EP2835001A4 (en) | IDENTIFICATION FOR DEVICES | |
| HK1257535A1 (zh) | 使用胎盤鑑定抗腫瘤化合物 | |
| HK1212895A1 (zh) | 用於免疫調節的沙奎那韋- | |
| GB201220419D0 (en) | Identification of materials | |
| GB201222952D0 (en) | Treatent of cancer |